OBJECTIVE:To evaluate technology innovation capability of pharmaceutical industry in 30 provinces(regions and cities)and explore suitable innovation mode for each type. METHODS:The entropy method was adopted to establish comprehen-sive evaluation mode of technology innovation capability of pharmaceutical industry. The mode was used to measure comprehensive score and ranking of pharmaceutical industry in 30 provinces(regions and cities). Those 30 provinces(regions and cities)were di-vided into 3 types,including high technology innovation ability (type Ⅰ),medium technology innovation ability (type Ⅱ) and low technology innovation ability (type Ⅲ),and relevant suggestions on innovation mode were put forward. RESULTS & CON-CLUSIONS:According to the establishment of evaluation index system that included innovation resources input capability,innova-tion output capability,innovation potentiality and innovation environment,significant differences were found among these regions in technology innovation capability. For those 8 provinces (regions and cities) with high technology innovation ability,such as Shandong,Jiangsu and so on,which belongs to the type Ⅰ,local pharmaceutical enterprises should adopt the innovation mode of independent innovation dominant,cooperative innovation as a supplement;for those 9 provinces(regions and cities)with medium technology innovation ability,such as Hebei,Sichuan and so on,which belongs to the type Ⅱ,local pharmaceutical enterprises should select the mode of cooperative innovation of the combination of production,teaching and research;for those 13 provinces (regions and cities) with low technology innovation ability,such as Hainan,Ningxia,which belongs to the type Ⅲ,should the mode of giving priority to imitation innovation and cooperative innovation as a supplement.

OBJECTIVE:To promote the development and make full use of the pharmacoeconomics(PE)in China.METHODS:The problems to be able to solved using PE,i.e the necessity of developing PE in China was discussed,and the bottleneck which will restrain or hinder the optimal utilization of PE was pointed out.RESULTS:We should strengthen the cultivation of talents engaged in PE,formulating guidelines of pharmacoeconomic evaluation and gradually apply PE into National Essential Medicine Policy.CONCLUSION:The decision-makers of health policy should have a sufficient understanding of PE so as to facilitate the utilization and sustainable development of PE in health policy-related decision-making.

OBJECTIVE:To provide reference for food & drug regulatory authorities in China to disclose government information.METHODS:In the light of the development and status quo of the disclosure of information in US FDA,the access,content and procedure for the disclosure of information in FDA were discussed.RESULTS & CONCLUSIONS:There are many similarities between US and China in the disclosure of information.In view of the practical situation of governmental information disclosure in food and drug regulatory authorities in China,Chinese government should be able to find out such key issues as the human and financial support is much needed in FDA information disclosure,the disclosure level should be in line with our national condition,a three-dimensional publicity system of government information at different level should be established and emphasis should be laid to the key disclosed information etc based on the research on the development,access,content and procedure of information disclosure in FDA.

OBJECTIVE:To provide references for drug manufacturing enterprises in dealing with the relationship be-tween enterprise brand and product brand.METHODS:The study of the relationship between enterprise brand and product brand was performed and the brand strategies of drug manufacturing enterprises were analyzed from aspects of enterprise brand and product brand.RESULTS&CONCLUSION:Brand strategies should be varied with different degrees of closeness of relationship between enterprise brand and product brand,drug enterprises should take different measures to exert the advan-tages of brand strategy while avoiding its disadvantages.

OBJECTIVE:To discuss the possible influence of the Regulation on the Stock Trade between Retailers and Suppliers(which was called in the following as “Regulation” for short) on drug retailing for the reference of drug retailers and suppliers.METHODS:The origin and the status quo of “Regulation” were studied and the influence of which on drug retailing was analyzed.RESULTS & CONCLUSION:Drug retailing was considerably influenced by policy factor,this issue of “Regula_tion” may change some unfair business behaviors such as delaying in payment and charging unreasonable entrance fee,and influences the strength contrast between drug retailers and suppliers.

OBJECTIVE:To facilitate a better understanding of the European Union(EU)herbal drugs market for Chinese TCM enterprises and to promote the internationalization of Chinese traditional medicines.METHODS:The opportunities and challenges confronted by TCM enterprises in their expanding of their products in the EU herbal medicine market were analyzed based on the knowledge about market size,market segmentation,consumption patters and developmental tendencies of the EU herbal medicine market.RESULTS&CONCLUSIONS:There were both opportunities and challenges for the expanding of traditional Chinese medicines in the EU herbal medicine market,yet on the whole,the opportunities were more than the challenge.Chinese enterprises should strive to further expand the EU herbal medicine market.

OBJECTIVE:To put forward proposals for governments on how to properly regulate drug market.METHODS:The theory of price elasticity in economics was applied for the analysis.RESULTS & CONCLUSIONS:With the increasing of national income year by year,the cases for high price drugs to expel low price drugs has become increasingly common.The government policies should be based on the development of pharmaceutical industry,meanwhile government should take mild policy to ease the contradictions arose from the development.

OBJECTIVE:To provide the ideas about how the chain drugstores to reply to drug price war.METHODS:Economically,the competition between drugstore was discussed and the respective advantages and disadvantages of fair-price and chain drugstores were analysed.RESULTS &CONCLUSION:Chain drugstores should improve their pharmaceutical service,base oneself upon market voids,and exert self-advantages,if they want to win in price war.

OBJECTIVE:To promote the reasonable use of antibiotic drugs.METHODS:the causes of antibiotics drug abuse were analyzed.The regulation on standardizing antibiotic drug sales by State Food and Drug Administration as well as its influence were discussed.RESULTS&CONCLUSION:some conceptions and suggestions are tentatively put forward.

OBJECTIVE:To provide advices on how to apply to the theory of customer relationship management in retail drugstores.METHODS:The theory of customer relationship management was briefly expounded and its application in the real management of drugstores was analyzed.RESULTS&CONCLUSION:Only after the retail drugstore putting the ideas of customer relationship management into their everyday work according to their own features can their function brought into full play.